MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
23.53
-2.49
-9.57%
After Hours: 23.53 0 0.00% 16:45 01/09 EST
OPEN
24.64
PREV CLOSE
26.02
HIGH
24.91
LOW
22.52
VOLUME
2.44M
TURNOVER
--
52 WEEK HIGH
27.64
52 WEEK LOW
18.17
MARKET CAP
1.01B
P/E (TTM)
50.45
1D
5D
1M
3M
1Y
5Y
1D
Jefferies Remains a Buy on Pacira Pharmaceuticals (PCRX)
TipRanks · 17h ago
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)
TipRanks · 18h ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 19h ago
What Analysts Are Saying About Pacira BioSciences Stock
Benzinga · 19h ago
Pacira BioSciences Price Target Maintained With a $38.00/Share by HC Wainwright & Co.
Dow Jones · 19h ago
Pacira Biosciences: Exparel-Led Growth and Discounted Valuation Support Attractive Risk–Reward and Buy Rating
TipRanks · 19h ago
HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $38 Price Target
Benzinga · 19h ago
Pacira BioSciences Price Target Maintained With a $30.00/Share by Needham
Dow Jones · 21h ago
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.